General Information of the Compound
| Compound ID |
CP0385829
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R)-2-[(8S)-1-chloro-3-(cyclopropylmethyl)-8-[2-[4-(trifluoromethyl)phenyl]ethyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-N-methyl-2-phenylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H30ClF3N4O
|
||||||||||||||||||
| Molecular Weight |
531.022
|
||||||||||||||||||
| Canonical SMILES |
CNC(=O)[C@H](N1CCn2c(CC3CC3)nc(Cl)c2[C@@H]1CCc1ccc(cc1)C(F)(F)F)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H30ClF3N4O/c1-33-27(37)24(20-5-3-2-4-6-20)35-15-16-36-23(17-19-7-8-19)34-26(29)25(36)22(35)14-11-18-9-12-21(13-10-18)28(30,31)32/h2-6,9-10,12-13,19,22,24H,7-8,11,14-17H2,1H3,(H,33,37)/t22-,24+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LPTIYNOSMVKYRM-LADGPHEKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1